NDC11 69097021002
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 69097-0210-02 | 69097-0210 |
| 69097-0210-2 | 69097-0210 |
| 69097-210-02 | 69097-210 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| efavirenz, emtricitabine and tenofovir disoproxil fumarate | EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | Cipla USA Inc. | a7d94a1c-31b0-4272-8f8d-186d580e16e0 | 2021-03-11 | Boxed warning, Warnings, Adverse reactions | 69097-210-02 69097-210 69097021002 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.